NCT07779109
- Conditions
- Endometrial Cancer, Endometrial Cancer Stage III, Endometrial Neoplasms, +14 more
- Locations
-
- Unidad Clínica Multihospitalaria de Oncología Radioterápica de Aragón (UCMORA) Zaragoza, Spain
Clinical trial condition
SBRT
Explore clinical trials studying SBRT. Study availability and eligibility vary by location and protocol.
14 public trials
4 recruiting studies
SBRT trial results
NCT07441941
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Montpellier Cancer Institut Montpellier, ICM, France
- Lorraine Cancer Institute Vandœuvre-lès-Nancy, France
NCT05344235
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
- Locations
-
- UZ Leuven Leuven, Vlaams Brabant, Belgium
NCT06219980
- Conditions
- Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +9 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Not yet recruiting
ADC and SBRT for Recurrent/Metastatic Salivary Gland Carcinoma
NCT07579598
- Conditions
- Adenoid Cystic Carcinoma of the Head and Neck, Antibody-drug Conjugates, SBRT
- Locations
-
Not specified
Not yet recruiting
Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy
NCT07537777
- Conditions
- Adenocarcinoma, Anlotinib, Benmelstobart, +14 more
- Locations
-
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
NCT06722495
- Conditions
- LA HNSCC, Neoadjuvant Immunochemotherapy, SBRT
- Locations
-
- Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University Guangzhou, Guangdong, China
Not yet recruiting
SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma
NCT06538935
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
Not specified
Enrolling by invitation
A Phase I Dose-escalation Trial of Definitive Single Dose Stereotactic Body Radiotherapy in Low-risk Breast Cancer Patients: DESERT I Trial
NCT06671691
- Conditions
- Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Hospital Universitario Son Espases Palma, Balearic Islands, Spain
Active, not recruiting
Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver Cancer
NCT07230080
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Nanfang Hosptial Guangzhou, China